Cogent Biosciences, Inc. (COGT) /
The revenue of Cogent Biosciences, Inc. over the past 9 years
Chart Cogent Biosciences, Inc.: revenue, fiscal 2017–2025 Open the chart →Cogent Biosciences, Inc. reported revenue of $7.87M in fiscal 2020. In fiscal 2017 it was $8.36M — down 5.8% over 3 years. Year over year, revenue rose twice and fell once. In these years the highest was $22.5M in fiscal 2019; the lowest $7.87M in fiscal 2020. The largest one-year move was in fiscal 2019: up 131%, from $9.73M to $22.5M. No revenue figure is on file for fiscal 2021, 2022, 2023, 2024 and 2025.
Year by year
| Fiscal year | Revenue |
|---|---|
| 2025ended Dec 31, 2025 | — |
| 2024ended Dec 31, 2024 | — |
| 2023ended Dec 31, 2023 | — |
| 2022ended Dec 31, 2022 | — |
| 2021ended Dec 31, 2021 | — |
| 2020ended Dec 31, 2020 | $7.87M |
| 2019ended Dec 31, 2019 | $22.5M |
| 2018ended Dec 31, 2018 | $9.73M |
| 2017ended Dec 31, 2017 | $8.36M |
Fiscal years as Cogent Biosciences, Inc. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on Cogent Biosciences, Inc.
- The profitability of Cogent Biosciences, Inc.
- The cash flow of Cogent Biosciences, Inc.
- The debt of Cogent Biosciences, Inc.
- All of Cogent Biosciences, Inc.'s financials, charted
Companies of a similar size
- RITMRithm Capital Corp.
- IBPInstalled Building Products, Inc.
- AMTMAmentum Holdings, Inc.
- PSNParsons Corporation
- PECOPhillips Edison & Company, Inc.
Not investment advice. This page shows what Cogent Biosciences, Inc. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.